Earnings Per Share, Basic in USD/shares of RIGEL PHARMACEUTICALS INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2010 to Q3 2025.
  • Rigel Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was 1.55 USD/shares, a 118% increase year-over-year.
  • Rigel Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 6 USD/shares.
  • Rigel Pharmaceuticals Inc annual Earnings Per Share, Basic for 2024 was 0.99 USD/shares.
  • Rigel Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -1.44 USD/shares, a 58.1% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -3.44 USD/shares, a 3027% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $6.00 $1.55 +$0.84 +118% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $5.00 $3.33 +$3.39 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $2.00 $0.64 +$1.11 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q4 2024 $0 $0.81 +$1.46 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025
Q3 2024 $0 $0.71 +$1.04 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 -$1 $0 +$0.32 +84.2% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 -$1 $0 $0 -488% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q4 2023 -$1 -$1 +$2.44 +79% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025
Q3 2023 -$3 $0 $0 -200% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$3 $0 $0 -375% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 -$3 $0 +$0.08 +50% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$3 -$3 -$3 -2107% 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025
Q3 2022 $0 $0 +$0.01 +8.33% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $0 $0 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023
Q1 2022 $0 $0 $0 -170% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 $0 $0 $0 -7.69% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024
Q3 2021 $0 $0 $0 -50% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $0 $0 +$0.02 +20% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 $0 $0.23 +$0.10 +76.9% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 $0 $0 01 Oct 2020 31 Dec 2020 10-K 07 Mar 2023
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021
Q2 2020 $0 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 $0.13 +$0.24 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q1 2019 $0 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q3 2012 $0 $0 -44% 01 Jul 2012 30 Sep 2012 10-Q 06 Nov 2012
Q2 2012 $0 +$0.02 +5.41% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2012
Q3 2011 $0 -$1 -126% 01 Jul 2011 30 Sep 2011 10-Q 06 Nov 2012
Q2 2011 $0 -$1 -171% 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012
Q3 2010 $0.97 01 Jul 2010 30 Sep 2010 10-Q 01 Nov 2011
Q2 2010 $0.52 01 Apr 2010 30 Jun 2010 10-Q 02 Aug 2011

RIGEL PHARMACEUTICALS INC Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0.99 +$2.43 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025
2023 -$1 +$2.00 +58.1% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025
2022 -$3 -$3 -3027% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025
2021 $0 +$0.07 +38.9% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024
2020 $0 +$0.22 +55% 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2023
2019 $0 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2012 -$1 +$0.04 +2.94% 01 Jan 2012 31 Dec 2012 10-K 05 Mar 2013
2011 -$1 -$2 -286% 01 Jan 2011 31 Dec 2011 10-K 05 Mar 2013
2010 $0.73 01 Jan 2010 31 Dec 2010 10-K 05 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.